NASDAQ:ESPR

Esperion Therapeutics Stock Predictions

NASDAQ Stock Exchange > Healthcare > Drug Manufacturers—Specialty & Generic

Open Broker Account

$2.48

+0.120 (+5.08%)

At Close: May 20, 2024

Currently predicting for Tue, 21 May 2024

Trading levels for ESPR

Fibonacci Support & Resistance Levels

		Level	Price
	Resistance	R3	2.66	7.21 %
		R2	2.59	4.30 %
		R1	2.54	2.50 %
Current price:			2.48
	Support	S1	2.40	-3.33 %
		S2	2.35	-5.13 %
		S3	2.28	-8.04 %

Accumulated Volume Support & Resistance Levels

		Level	Price
	Resistance	R3	2.79	12.50 %
		R2	2.70	8.87 %
		R1	2.62	5.65 %
Current price			2.48
	Support	S1	2.37	-4.44%
		S2	2.19	-11.69%
		S3	2.04	-17.74%

ESPR Predictions History

7 years ago
JS predicted that ESPR for 2017-03-20 is going $22.88 (-3.34%)

7 years ago
Uday.V.4287 predicted that ESPR for 2017-03-20 is going $26.00 (9.84%)

Rank:

About Esperion Therapeutics

Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascular disease or heterozygous familial hypercholesterolemia. The company has a license and collaboration a... ESPR Profile

Golden Star

Ticker	Date	Change	Price
TTWO	May 16	3.30%	$146.08
LYV	May 16	3.16%	$96.38
BDX	May 16	0.216%	$236.62
CNI	May 16	1.30%	$126.57
INBX	May 15	0.262%	$34.37
PAGS	May 15	1.88%	$12.74
LNG	May 14	1.51%	$157.42
CME	May 14	0.223%	$210.80
VGIT	May 14	0.0692%	$57.83
VCLT	May 14	0.621%	$75.73

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by

Sign In